Genomic Correlates of Chemoradiation Response in Locally Advanced Cervical Cancer: Implications for Precision Oncology
Cancer Science · 18.11.2026
DOI: 10.1111/cas.70601 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Science, online erschienen am 18.11.2026. Verfasst von Vito Filbert Jayalie und 15 weiteren Autor:innen. Beteiligte Einrichtung: Philosophy Doctor in Medicine Program, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Doctoral Scholarship Program for Indonesian Lecturers (BPDDI), Center for Higher Education Funding and Assessment (PPAPT), Ministry of Higher Education, Science and Technology of Republic Indonesia.
Abstract (Originalsprache)
Locally advanced cervical cancer (LACC) accounts for a major healthcare burden in low‐ and middle‐income countries, where five‐year overall survival remains below 75% despite concurrent chemoradiation therapy (CCRT) as the curative standard. Treatment response is highly variable, yet clinical management is largely uniform. This review synthesizes current evidence on the genomic correlates of CCRT in LACC, spanning alterations in PIK3CA, PTEN, TP53, KRAS, ARID1A, and APOBEC‐driven mutational signatures. These pathways offer biologically coherent explanations for radioresistance, but the strength and maturity of supporting evidence vary considerably, and evidence for most markers remains prognostic rather than treatment‐predictive. No single genomic marker yet supports routine clinical use, and genome‐only models omit complementary contributions from the tumor microenvironment, hypoxia, cancer stem cell biology, and clinicopathological or imaging‐derived parameters. We further discuss the translational gap between genomic discovery and clinical implementation, with particular attention to population representation and resource constraints in high‐burden settings. Prospective, population‐inclusive genomic trials are urgently needed to translate these findings into equitable precision radiotherapy for patients with LACC worldwide.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Philosophy Doctor in Medicine Program, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
- Faculty of Medicine, Universitas Imelda Medan, Medan, Indonesia.
- Department of Radiation Oncology, Murni Teguh Memorial Hospital, Medan, Indonesia.
- Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
- Department of Radiation Oncology, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
- National Cancer Centre Singapore, Singapore, Singapore.
ORCID-Profile: Vito Filbert Jayalie, Jason Yongsheng Chan
Förderung
- Doctoral Scholarship Program for Indonesian Lecturers (BPDDI)
- Center for Higher Education Funding and Assessment (PPAPT)
- Ministry of Higher Education, Science and Technology of Republic Indonesia
Zitieren
APA
Jayalie, V. F., Rusda, M., Gondhowiardjo, S. A., Chan, J. Y., Teh, B. T., Widjaja, S. S., Dina, S., Siregar, K. B., Edianto, D., Adella, C. A., Satria, F. B., Handoko, Annisa, M. F., Pratama, M. A., Ritonga, I. L., & Ichwan, M. (2026). Genomic Correlates of Chemoradiation Response in Locally Advanced Cervical Cancer: Implications for Precision Oncology. Cancer Science. https://doi.org/10.1111/cas.70601
Vancouver
Jayalie VF, Rusda M, Gondhowiardjo SA, Chan JY, Teh BT, Widjaja SS, et al. Genomic Correlates of Chemoradiation Response in Locally Advanced Cervical Cancer: Implications for Precision Oncology. Cancer Science. 2026. doi:10.1111/cas.70601
BibTeX
@article{Jayalie2026,
author = {Jayalie, Vito Filbert and Rusda, Muhammad and Gondhowiardjo, Soehartati A and Chan, Jason Yongsheng and Teh, Bin Tean and Widjaja, Sry Suryani and Dina, Sarah and Siregar, Kamal Basri and Edianto, Deri and Adella, Cut Adeya and Satria, Fauzi Budi and Handoko and Annisa, Meuthia Faralita and Pratama, Muhammad Arief and Ritonga, Imelda Liana and Ichwan, M},
title = {Genomic Correlates of Chemoradiation Response in Locally Advanced Cervical Cancer: Implications for Precision Oncology},
journal = {Cancer Science},
year = {2026},
doi = {10.1111/cas.70601}
}
EUVIMED